Tim Wingard

Tim Wingard, a healthcare investment expert at TD Epic, dives into the transformative world of GLP-1 drugs. He discusses their origins and the groundbreaking success of semaglutide in weight loss. Wingard reveals how these drugs could reduce healthcare costs related to obesity and speculates on societal impacts like reduced calorie consumption. He also touches on the potential links between GLP-1s and Alzheimer's research, alongside the challenges of long-term adherence and side effects. This conversation uncovers the multifaceted implications of a drug revolution.